Connecticut Children’s Medical Center has agreed to stop giving sex-change drugs to minors after the Department of Justice intervened, the agency announced Wednesday. The agreement represents a significant development in the ongoing national debate over medical interventions for minors experiencing gender dysphoria, particularly as federal enforcement priorities have shifted under the current administration.
The medical center will also pay a monetary penalty and dedicate an additional $500,000 in medical care for individuals harmed by sex-mutilating drugs. This financial commitment is intended to address the medical needs of patients who received treatments at the facility and may require ongoing care or interventions to address complications or long-term effects.
The resolution came from an ongoing DOJ investigation into potential violations of federal law connected to sex-change drugs and surgeries performed on children. The investigation is part of a broader federal effort to examine whether such medical interventions on minors violate existing statutes related to healthcare fraud, informed consent, or the protection of vulnerable populations. The DOJ has indicated that multiple facilities across the country remain under scrutiny as part of this enforcement initiative.
“THE DEPARTMENT OF JUSTICE WILL STOP AT NOTHING TO PROTECT AMERICA’S CHILDREN.”
Associate Attorney General Stanley Woodward made clear the administration’s position on the issue. His statement reflects the DOJ’s elevated prioritization of investigations into pediatric medical practices that the administration views as potentially harmful or experimental in nature.
“This resolution is a reminder to hospitals, medical providers, and pharmaceutical companies that the Justice Department will vigorously enforce federal law, especially where the lives of children are endangered,” Woodward said. The statement signals that enforcement actions may extend beyond hospitals to include other entities involved in the provision or distribution of medical treatments for gender-related care in minors.
The DOJ credited Connecticut Children’s for cooperation throughout the investigation. The agency highlighted the medical center’s “financial commitment to providing restorative care to the victims who desperately need it.” This cooperative approach allowed the matter to be resolved without protracted litigation, which could have taken years and exposed both parties to considerable legal expenses and uncertainty.
This marks the third major victory for the Trump administration’s DOJ in stopping experimental sex-change procedures on children. The pattern of settlements suggests that federal authorities are pursuing a coordinated enforcement strategy targeting prominent medical institutions across different regions of the country.
Connecticut Children’s follows Texas Children’s Hospital and the Cleveland Clinic Foundation in reaching similar agreements with federal authorities. The three institutions are among the largest and most respected pediatric healthcare providers in their respective regions, making these agreements particularly significant in terms of their potential impact on medical practice standards nationwide.
“As with Texas Children’s and Cleveland Clinic before it, I am encouraged when leading institutions like Connecticut Children’s agree to be part of the solution and no longer the problem,” said Brett Shumate, Assistant Attorney General for the Civil Division. His comments suggest the administration views these agreements as setting precedents that may influence the decisions of other medical providers currently offering similar treatments.
Shumate warned that the department won’t back down from pursuing justice for victims of what he called “discredited practices.” The characterization reflects the administration’s view that current medical evidence does not sufficiently support the use of hormonal interventions and surgical procedures for minors experiencing gender-related distress.
The medical center confirmed the resolution in a statement to the Hartford Courant, emphasizing that patient privacy remained protected throughout the process. The institution’s response was measured and brief, likely reflecting legal counsel’s advice regarding ongoing compliance obligations and the sensitive nature of the matter.
“We have complied and will continue to comply with all federal and state laws,” the statement reads. The language underscores the facility’s commitment to operating within all applicable regulatory frameworks, even as those frameworks evolve under changing federal enforcement priorities.
The DOJ noted that the agreements are based on allegations only and that Connecticut Children’s has denied all allegations. This acknowledgment is standard in settlement agreements where parties resolve disputes without admission of wrongdoing or liability.
The charges remain allegations. The case has not been proven in court. The settlement therefore does not constitute a legal determination regarding whether any violations actually occurred, but rather represents a negotiated resolution that both parties found preferable to continued investigation or litigation.
